We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Cleveland-Cliffs
CLF
$6.57B
| $16K | ﹤0.01% |
+1,120
| New | +$11.3K |
|
977
Carpenter Technology
CRS
$25.8B
| $16K | ﹤0.01% |
+542
| New | +$12.6K |
|
978
Dine Brands
DIN
$456M
| $16K | ﹤0.01% |
+280
| New | +$17K |
|
979
Franklin Electric
FELE
$4.63B
| $16K | ﹤0.01% |
+234
| New | +$15.4K |
|
980
Fresenius Medical Care
FMS
$13.8B
| $16K | ﹤0.01% |
+375
| New | +$15.6K |
|
981
Fossil Group
FOSL
$293M
| $16K | ﹤0.01% |
+1,864
| New | +$15.7K |
|
982
Forrester Research
FORR
$223M
| $16K | ﹤0.01% |
+378
| New | +$15.1K |
|
983
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$147M
| $16K | ﹤0.01% |
+367
| New | +$15.7K |
|
984
Quaker Houghton
KWR
$2.76B
| $16K | ﹤0.01% |
+63
| New | +$14.2K |
|
|
MZTI
985
The Marzetti Company
MZTI
$2.93B
| $16K | ﹤0.01% |
+85
| New | +$14.8K |
|
986
Quanex
NX
$819M
| $16K | ﹤0.01% |
+742
| New | +$15.3K |
|
987
OraSure Technologies
OSUR
$279M
| $16K | ﹤0.01% |
+1,544
| New | +$20.3K |
|
988
RELX
RELX
$61.8B
| $16K | ﹤0.01% |
+634
| New | +$14.5K |
|
989
Rockwell Automation
ROK
$53.4B
| $16K | ﹤0.01% |
+63
| New | +$15.4K |
|
990
Roper Technologies
ROP
$38.8B
| $16K | ﹤0.01% |
+36
| New | +$14.8K |
|
|
SKX
991
DELISTED
Skechers
SKX
| $16K | ﹤0.01% |
+445
| New | +$15.1K |
|
992
Synaptics
SYNA
$4.19B
| $16K | ﹤0.01% |
+165
| New | +$13.4K |
|
993
Teledyne Technologies
TDY
$30.4B
| $16K | ﹤0.01% |
+40
| New | +$14.3K |
|
994
TechTarget
TTGT
$325M
| $16K | ﹤0.01% |
+276
| New | +$14.3K |
|
995
Unilever
UL
$137B
| $16K | ﹤0.01% |
+230
| New | +$15.6K |
|
996
Vontier
VNT
$4.52B
| $16K | ﹤0.01% |
+480
| New | +$14.8K |
|
|
SPPI
997
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $16K | ﹤0.01% |
+4,666
| New | +$19.2K |
|
|
FLOW
998
DELISTED
SPX FLOW, Inc.
FLOW
| $16K | ﹤0.01% |
+284
| New | +$14.5K |
|
|
KRA
999
DELISTED
Kraton Corporation
KRA
| $16K | ﹤0.01% |
+592
| New | +$16K |
|
|
CMO
1000
DELISTED
Capstead Mortgage Corp.
CMO
| $16K | ﹤0.01% |
+2,798
| New | +$16K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.